No Data
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Ionis Pharmaceuticals Price Target Cut to $45.00/Share From $47.00 by JP Morgan
Ionis Pharmaceuticals Is Maintained at Neutral by JP Morgan
Praxis Precision Medicines to Present on Late-Stage Programs Across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting
J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $45
Why Is Ionis Pharmaceuticals (IONS) Up 0.1% Since Last Earnings Report?
